The Global Rapid Diagnostic Tests (RDT) Market is growing with the increasing prevalence of chronic diseases and increasing product launches by major market players. However, the growing product recall may obstruct the growth of the market in the given forecast period.
Global Rapid Diagnostic Tests (RDT) Market Scenario
According to Data Bridge Market Research, the global rapid diagnostic tests (RDT) market in North American region has the highest market share. The market leader is Abbott which accounts for an estimated market share of approximately 22.36%. The company has gained outstanding sales through providing rapid diagnostic tests (RDT) products and devices.
For instance,
- In February 2019, Abbott launched the most sensitive rapid diagnostic test Determine HBsAg 2, to detect hepatitis B antigens. This test device uses whole blood, serum, and even plasma sample for the detection process. The launch of this lateral flow technology helped the company to enhance its platform for capillary blood collection devices
Trends Impacting the Market
Now the question is which other regions Abbott, F. Hoffmann-La Roche Ltd, and Siemens Healthcare Gmbh (A Subsidiary Siemens Healthineers AG) are targeting? Data Bridge Market Research has estimated a large growth in North America rapid diagnostic tests (RDT) market, and the market leaders are targeting the U.S., Canada, and Mexico to be their next revenue pockets for 2022.
The global rapid diagnostic tests (RDT) market is becoming more competitive with companies such as Abbott, F. Hoffmann-La Roche Ltd, and Siemens Healthcare Gmbh (A Subsidiary Siemens Healthineers AG). They are the top dominating companies in the global rapid diagnostic tests (RDT) market, having a maximum number of products. Data Bridge Market Research's new reports highlight the major growth factors and opportunities in the global rapid diagnostic tests (RDT) market.
For more analysis on the global rapid diagnostic tests (RDT) market, request a briefing with our analysts https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=global-rapid-diagnostic-tests-rdt-market
Global Rapid Diagnostic Tests (RDT) Market Development
- In April 2020, Siemens Healthcare GmbH had received approval from the Food and Drug Administration (FDA) for the Rapidpoint 500e Blood Gas Analyzer. The Rapidpoint 500e Blood Gas Analyzer is used treatment of patients suffering from cardiac diseases. The approval received would result in the availability of the Rapidpoint 500e Blood Gas Analyzer in acute care settings such as home and ambulatory surgical centers. This approval increased the partnerships and collaborations of the Siemens Healthcare GmbH with hospitals and diagnostic centers
Scope of the Global Rapid Diagnostic Tests (RDT) Market
The global rapid diagnostic tests (RDT) market is segmented based on geography into North America, Europe, Asia-Pacific, Africa, and according to the countries such as the U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzerland, Rest Of Europe, China, Japan, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines and Rest Of Asia-Pacific, South Africa, Nigeria, Ethiopia and Rest of Africa.
All country-based analysis of the global rapid diagnostic tests (RDT) market is further analyzed based on further segmentation. The global rapid diagnostic tests (RDT) market is categorized into eleven notable segments based on product type, mode, technology, modality, age group, test type, approach, specimen, application, end user, and distribution channel.
- On the basis of product type, the global rapid diagnostic tests (RDT) market is segmented into consumables and kits, instruments, and others. On the basis of mode, the global rapid diagnostic tests (RDT) market is segmented into professional rapid diagnostic test product, and over-the-counter [OTC] rapid diagnostic test product. On the basis of technology, the global rapid diagnostic tests (RDT) market is segmented into PCR-based, flow-through assays, lateral flow immunochromatographic assays, agglutination assay, microfluidics, substrate technology, and others. On the basis of modality, the global rapid diagnostic tests (RDT) market is segmented into laboratory based test and non-laboratory based test. On the basis of age group, the global rapid diagnostic tests (RDT) market is segmented into adult and pediatric. On the basis of test type, the global rapid diagnostic tests (RDT) market is segmented into determining confirmation, serological testing, and viral sequencing. On the basis of approach, the global rapid diagnostic tests (RDT) market is segmented into in-vitro diagnostic and molecular diagnostic. On the basis of specimen, the global rapid diagnostic tests (RDT) market is segmented into swab, blood, urine, saliva, sputum, and others. On the basis of application, the global rapid diagnostic tests (RDT) market is segmented into infectious disease testing, glucose monitoring, cardiology testing, oncology testing, cardiometabolic testing, drugs-of-abuse testing, pregnancy & fertility testing, toxicology testing, and others. On the basis of end user, the global rapid diagnostic tests (RDT) market is segmented into hospital & clinic, diagnostic laboratory, home care setting, research and academic institutes, and others. On the basis of distribution channel, the global rapid diagnostic tests (RDT) market is segmented into direct tender, retail sales, and others.
To know more about the study https://www.databridgemarketresearch.com/reports/global-rapid-diagnostic-tests-rdt-market
Key Pointers Covered in Global Rapid Diagnostic Tests (RDT) Market Industry Trends and Forecast to 2029
- Market Size
- Top to Bottom Market Analysis
- Recent Developments for Market Competitors
- Recent Market Value for Different Countries
Key Market Competitors Covered in the Report
- Abbott
- Danaher
- Cellex
- AdvaCare Pharma
- Access Bio
- Cardinal Health
- Bio-Rad Laboratories, Inc.
- BD
- F. Hoffmann-La Roche Ltd
- bioMérieux SA
- InBios International, Inc.
- Gnomegen LLC
- QIAGEN
- Quidel Corporation
- Chembio Diagnostics Systems, Inc.
- Siemens Healthcare Gmbh (A Subsidiary Siemens Healthineers AG)
- PerkinElmer Inc.
- Sekisui Diagnostics
- Fujirebio (A Subsidiary of H.U. Group)
- PTS Diagnostics
- LamdaGen Corporation
- Werfen
- Nova Biomedical
- Trinity Biotech
- Sysmex Europe GmbH (A Subsidiary of Sysmex Corporation)
- Luminex Corporation. A DiaSorin Company
- MEGAKOR DIAGNOSTK GMBH
Above are the key players covered in the report. To know about more and exhaustive list of rapid diagnostic tests (RDT) market companies’, contact us https://www.databridgemarketresearch.com/toc/?dbmr=global-rapid-diagnostic-tests-rdt-market
Research Methodology: Global Rapid Diagnostic Tests (RDT) Market
Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or can drop down your inquiry.
The key research methodology used by the DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include vendor positioning grid, market timeline analysis, market overview and guide, company positioning grid, company market share analysis, standards of measurement, top to bottom analysis, and vendor share analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Primary Respondents
- Demand Side: Pharmacists, Hospitals, Clinicians and Technicians, Academic Professionals and Researchers
- Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers, among others.
Related Reports
- Global Immunoassay Reagents and Devices Market - Industry Trends and Forecast to 2029
- Global Rapid Immunoassay Test - Industry Trends and Forecast to 2029
- Global ELISA Tests Market - Industry Trends and Forecast to 2029
Browse in Healthcare Category Related Reports@ https://www.databridgemarketresearch.com/report-category/healthcare/
